India-Greece Collaboration in Pharma and Defence

Indian Prime Minister Narendra Modi and Greek Prime Minister Kyriakos Mitsotakis are committed to enhancing cooperation across multiple sectors, including technology, pharmaceuticals, skill development, space, and innovation.

IPC's New Draft: Advancing Pharmacovigilance in Pharmaceuticals

The Indian Pharmacopoeia Commission (IPC) has released the Draft Pharmacovigilance Guidance Document for Pharmaceutical Products in its latest version, Version 2.0.

Jharkhand's Drug Quality Workshop for North Suppliers

The drug regulatory department in the state of Jharkhand is planning to conduct a workshop to raise awareness on maintaining the quality of medicines for the drug manufacturers and distributors who supply medicines for the state's needs.

Aptar Digital Health Acquires Healint To Bolster Digital Health Portfolio

Aptar Digital Health, which offers digital health solutions globally, has recently acquired Healint, a digital health company based in Singapore. According to Aptar Digital Health, the acquisition of Healint is in line with their plan to expand...

Optimizing Genetic Tests for Health Equity

A scientific team funded by the National Institutes of Health (NIH) has found new ways to improve the accuracy of a genetic testing method called a polygenic risk score.

Wuxi ATU Gets FDA Nod for Amtagvi Production in Advanced Melanoma

WuXi Advanced Therapies (WuXi ATU), a subsidiary of WuXi AppTec, announced that its Philadelphia site has received FDA approval to begin analytical testing and manufacturing of Amtagvi for Iovance.

NIH Precision Medicine Data Reveals 275M New Genetic Variants

Researchers found more than 275 million previously unreported genetic variants in data shared by nearly 250,000 National Institutes of Health's Global Research Program participants.

Innovative Meds: Global-Domestic Pharma Collaboration in India

Indian drug firms are exploring opportunities in the Kingdom of Saudi Arabia (KSA), an $8.9 billion pharmaceutical (pharma) market, as the latter is keen to procure more pharmaceutical products from India.

India Pharma Giants & Global Big Pharma Partner for NMEs in India

The pharma landscape has significantly shifted towards collaboration and partnership between global big pharma and Indian pharma firms in recent years to drive innovation and expand market reach.

Innovent Biologics Concludes Phase 3 Trial To Treat Thyroid Eye Disease

The primary endpoint in the phase 3 registrational study (RESTORE-1) of IBI311, a recombinant anti-insulin-like growth factor 1 receptor (IGF-1R) antibody, in Chinese subjects with thyroid eye disease (TED) has been achieved, according to...

© 2025 India Pharma Outlook. All Rights Reserved.